American Diabetes Association

Skip to Main Content

Table 2—

Baseline clinical characteristics^*

	Basal bolus	SSI
n	65	65
Age (years)	56 ± 13	56 ± 11
Race (white/black/Hispanic)	4/43/18	3/48/14
Sex (male/female)	42/23	21/44
BMI (kg/m²)	32 ± 8	32 ± 9
Length of hospital stay (days)	5.2 ± 6	5.1 ± 4
White blood cell ×10⁶	9.6 ± 4	8.7 ± 4
Hemoglobin (g)	13 ± 2	12.6 ± 2
Creatinine (mg/dl)	1.0 ± 0.5	1.1 ± 0.5
A1C (%)	8.9 ± 2	8.7 ± 2.5
Admission blood glucose (mg/dl)	229 ± 71	225 ± 60
Mean blood glucose during hospital stay (mg/dl)	166 ± 32	193 ± 54^*
Mean fasting blood glucose (mg/dl)	147 ± 36	165 ± 41^†
Mean random blood glucose (mg/dl)	164 ± 35	188 ± 45^*

	Basal bolus	SSI
n	65	65
Age (years)	56 ± 13	56 ± 11
Race (white/black/Hispanic)	4/43/18	3/48/14
Sex (male/female)	42/23	21/44
BMI (kg/m²)	32 ± 8	32 ± 9
Length of hospital stay (days)	5.2 ± 6	5.1 ± 4
White blood cell ×10⁶	9.6 ± 4	8.7 ± 4
Hemoglobin (g)	13 ± 2	12.6 ± 2
Creatinine (mg/dl)	1.0 ± 0.5	1.1 ± 0.5
A1C (%)	8.9 ± 2	8.7 ± 2.5
Admission blood glucose (mg/dl)	229 ± 71	225 ± 60
Mean blood glucose during hospital stay (mg/dl)	166 ± 32	193 ± 54^*
Mean fasting blood glucose (mg/dl)	147 ± 36	165 ± 41^†
Mean random blood glucose (mg/dl)	164 ± 35	188 ± 45^*

Data are means ± SD unless otherwise indicated.

*

P < 0.001.

†

P < 0.01.